Adscripción del farmacéutico a cuidados intensivos: generando sinergias

Sereno, María; Serrano, Rosario Mérida; Díaz-Miguel, R. Ortiz; González, Mercedes Catalán; Álvarez, H. Abdel-Hadi; Checa, A. Ambrós; Martı́nez, Mercedes

doi:10.1016/j.medin.2018.02.006

Cited by 2 publications

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The answer is YES, without a doubt [95,[127][128][129][130][131][132][133][134][135][136][137][138]. The reasons are detailed below: Studies conducted following scientific evidence criteria in recent years show that pharmaceutical care and the intervention of the pharmacist improve the overall quality of patient care, while the WHO itself states that point to a doubling of the number of older people by 2050.…”

Section: Does the Pharmacist Whether In The Hospital Or In The Commumentioning

confidence: 99%

The situation of infection in the elderly in Spain: a multidisciplinary opinion document

Bouza

Brenes²,

Domingo³

et al. 2020

Rev Esp Quimioter

View full text Add to dashboard Cite

Infection in the elderly is a huge issue whose treatment usually has partial and specific approaches. It is, moreover, one of the areas where intervention can have the most success in improving the quality of life of older patients. In an attempt to give the widest possible focus to this issue, the Health Sciences Foundation has convened experts from different areas to produce this position paper on Infection in the Elderly, so as to compare the opinions of expert doctors and nurses, pharmacists, journalists, representatives of elderly associations and concluding with the ethical aspects raised by the issue. The format is that of discussion of a series of pre-formulated questions that were discussed by all those present. We begin by discussing the concept of the elderly, the reasons for their predisposition to infection, the most frequent infections and their causes, and the workload and economic burden they place on society. We also considered whether we had the data to estimate the proportion of these infections that could be reduced by specific programmes, including vaccination programmes. In this context, the limited presence of this issue in the media, the position of scientific societies and patient associations on the issue and the ethical aspects raised by all this were discussed.

show abstract